首页> 外文期刊>Genetic Testing >Comparison of Amplification Refractory Mutation System and Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Techniques Used for the Investigation of MEFV Gene Exon 10 Point Mutations in Familial Mediterranean Fever Patients Living in
【24h】

Comparison of Amplification Refractory Mutation System and Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Techniques Used for the Investigation of MEFV Gene Exon 10 Point Mutations in Familial Mediterranean Fever Patients Living in

机译:扩增难治性突变系统和聚合酶链反应-限制性片段长度多态性技术在居住在地中海沿岸的地中海热患者MEFV基因外显子10点突变研究中的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Familial Mediterranean fever (FMF) is an autosomal recessive inherited disease characterized by recurrent fever, serositis and arthritis. The disease is highly prevalent in Mediterranean basin populations. Recently, the gene responsible for FMF (MEFV) was cloned and at least 40 MEFV gene mutations have been identified. The most frequently observed mutations in the MEFV gene are M694V, M694I, M680I, and V726A. These occur within exon 10 of the gene, and account for 85% of the known MEFV alleles. In this study, the reliability and economical aspects of amplification refractory mutation system (ARMS) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) techniques were compared for analyzing the frequencies of the major point mutations of 90 unrelated patients with FMF from the Cukurova region in Turkey. Both techniques yielded similar results: The ratio of independent alleles of 90 patients carrying one of the tested mutations was 81.1%; patients consisted of 12 different genotypes. In 64 of 90 patients (71.1%) mutations were observed in both alleles. Thirty-six patients (40%) were homozygous for the same mutation, 28 (31.1%) were heterozygous for different mutations. Eighteen patients (20%) were heterozygous for one al-lele with one of the four mutations but the other allele was unknown. In 8 patients (8.8%) no mutation could be detected. The most frequently observed mutation was M694V (51.66%), followed by M680I (17.22%), V726A (10.55%), and M694I (1.66%). In conclusion ARMS and PCR-RFLP techniques were equally reliable to detect the mutations in Turkish FMF patients. However, the ARMS technique was found to be more rapid and economical than the PCR-RFLP techniques.
机译:家族性地中海热(FMF)是一种常染色体隐性遗传性疾病,其特征为反复发烧,浆膜炎和关节炎。该病在地中海盆地人口中高度流行。最近,克隆了负责FMF的基因(MEFV),并已鉴定出至少40个MEFV基因突变。 MEFV基因中最常见的突变是M694V,M694I,M680I和V726A。这些发生在基因的外显子10内,占已知MEFV等位基因的85%。在这项研究中,比较了扩增难治性突变系统(ARMS)和聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术的可靠性和经济性,以分析90例非亲缘性FMF患者的主要点突变频率土耳其的库库洛娃地区。两种技术都产生了相似的结果:90位携带一种被测突变的患者的独立等位基因比例为81.1%。患者由12种不同的基因型组成。在两个等位基因中均观察到90位患者中的64位(71.1%)突变。三十六名患者(40%)为同一突变纯合子,二十八名患者(31.1%)为不同突变纯合子。 18名患者(20%)杂合了一个带有四个突变之一的al-lele,但另一个等位基因未知。在8例患者(8.8%)中,未检测到突变。观察到最频繁的突变是M694V(51.66%),其次是M680I(17.22%),V726A(10.55%)和M694I(1.66%)。总之,ARMS和PCR-RFLP技术在检测土耳其FMF患者中的突变方面同样可靠。但是,发现ARMS技术比PCR-RFLP技术更快速,更经济。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号